Craft
Zoetis

Zoetis

Countries

100

Q3, 2021

Revenue

$7.8 B

FY, 2021

Market Capitalization

$74.4 B

2022-09-19

Zoetis Summary

Company summary

Overview
Zoetis is a company engaged in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products. It offers vaccines, anti-infectives, parasiticides, other pharmaceutical products, dermatology, medicated feed additives, and animal health diagnostics for cattle, swine, poultry, fish, and sheep as well as dogs, cats, and horses.
Type
Public
Founded
2012
HQ
Parsippany-Troy Hills, NJ, US | view all locations
Website
https://www.zoetis.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Kristin Peck

    Kristin Peck, Chief Executive Officer and Director

  • Tim Bettington

    Tim Bettington, Executive Vice President and President, U.S. Operations and Global Customer Experience

  • Glenn David

    Glenn David, Executive Vice President and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance

  • Heidi Chen

    Heidi Chen, Executive Vice President, General Counsel & Corporate Secretary; Business Lead of Human Health Diagnostics

Operating MetricsView all

Countries

100

Q3, 2021

Floor Space, square feet

11.1M

FY, 2020

Product Lines

300

Q3, 2021

LocationsView all

49 locations detected

  • Parsippany-Troy Hills, NJ HQ

    United States

    10 Sylvan Way, Parsippany

  • Buenos Aires, CABA

    Argentina

    Virrey Loreto 2477

  • Silverwater, NSW

    Australia

  • Wien, Wien

    Austria

    Floridsdorfer Hauptstraße 1

  • Zaventem, Vlaanderen

    Belgium

    Mercuriusstraat 20

  • Sao Paulo, SP

    Brazil

    Rua Luiz Fernando Rodrigues 1701

and 43 others

Zoetis Financials

Summary financials

Revenue (Q2, 2022)
$2.1B
Gross profit (Q2, 2022)
$1.4B
Net income (Q2, 2022)
$529.0M
Cash (Q2, 2022)
$2.7B
Enterprise value
$78.3B

Footer menu